Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant

Patients with high-grade serous ovarian carcinoma (HGSC) exhibit poor 5-year survival rates, which may be significantly improved by early-stage detection. The U.S. Food and Drug Administration–approved biomarkers for HGSC—CA-125 (cancer antigen 125) and HE4 (human epididymis protein 4)—do not genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Ryan M., Lee, Christopher, Galassi, Thomas V., Harvey, Jackson D., Leicher, Rachel, Sirenko, Maria, Dorso, Madeline A., Shah, Janki, Olvera, Narciso, Dao, Fanny, Levine, Douglas A., Heller, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906074/
https://www.ncbi.nlm.nih.gov/pubmed/29675469
http://dx.doi.org/10.1126/sciadv.aaq1090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906074/
https://www.ncbi.nlm.nih.gov/pubmed/29675469
http://dx.doi.org/10.1126/sciadv.aaq1090

Ejemplares similares